EDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Edwards Lifesciences (EW) Tops Q2 EPS by 1c, Updates Guidance
July 26, 2023 4:27 PM EDTEdwards Lifesciences (NYSE: EW) reported Q2 EPS of $0.66, $0.01 better than the analyst estimate of $0.65. Revenue for the quarter came in at $1.53 billion versus the consensus estimate of $1.5 billion.
GUIDANCE:
Edwards Lifesciences sees FY2023 EPS of $2.50-$2.60, versus the consensus of $2.55.... More



